6.27MMarket Cap
LossP/E TTM
PharmaCyte Biotech Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of PharmaCyte Biotech Inc is 8.50, ranking 92 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.65, which is -3484.55% below the recent high of 21.89 and -2120.05% above the recent low of -14.36.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.